Filing Details
- Accession Number:
- 0001213900-17-006860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-27 16:23:30
- Reporting Period:
- 2017-06-23
- Filing Date:
- 2017-06-27
- Accepted Time:
- 2017-06-27 16:23:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690080 | Kbl Merger Corp. Iv | KBLMU | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033308 | Marlene Krauss | 527 Stanton Christiana Rd. Newark DE 19713 | Chief Executive Officer | Yes | Yes | Yes | No |
1706868 | Kbl Iv Sponsor Llc | 527 Stanton Christiana Road Newark DE 19713 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-23 | 27,500 | $10.00 | 3,252,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares are underlying units (each unit consisting of one share of common stock, one right entitling the holder thereof to receive one-tenth (1/10) of one share of common stock upon the consummation of an initial business combination and one warrant to purchase one-half of one share of common stock) held by KBL IV Sponsor LLC (the "Sponsor"), acquired pursuant to a third amended and restated unit purchase agreement by and between the Sponsor and the issuer.
- Such units were purchased upon the exercise of the underwriters' over-allotment option in connection with the issuer's initial public offering.
- Each of the issuer's officers and directors is a member of the Sponsor. Dr. Marlene Krauss, the issuer's Chief Executive Officer, is the sole managing member of the Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by the Sponsor and has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by the Sponsor in which she does not have a pecuniary interest.